CHMP Recommends Denecimig for Hemophilia A
EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending authorization of denecimig (Frehemgo) for routine prophylaxis of bleeding in patients of all ages with hemophilia A, with or without factor…
